1. Uhlig T, Moe RH, Kvien TK. The burden of disease in rheumatoid arthritis. Pharmacoeconomics.
2014;32:841–51. doi:10.1007/s40273-014-0174-6.
2. McBurney CA, Vina ER. Racial and ethnic disparities in rheumatoid arthritis. Curr
Rheumatol Rep. 2012;14:463–71. doi:10.1007/s11926-012-0276-0.
3. Chemin K, Klareskog L, Malmström V. Is rheumatoid arthritis an autoimmune disease?
Curr Opin Rheumatol. 2016;28:181–8. doi:10.1097/BOR.0000000000000253.
4. Nell VPK, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very
early referral and very early therapy with disease-modifying anti-rheumatic drugs
in patients with early rheumatoid arthritis. Rheumatology. 2004;43:906–14. doi:10.1093/rheumatology/keh199.
5. Møller-Bisgaard S, Hørslev-Petersen K, Ejbjerg B, Hetland ML, Ørnbjerg LM, Glinatsi
D, et al. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies
on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis:
The IMAGINE-RA Randomized Clinical Trial. JAMA. 2019;321:461–72. doi:10.1001/jama.2018.21362.
6. McQueen FM, Ostendorf B. What is MRI bone oedema in rheumatoid arthritis and why
does it matter? Arthritis Res Ther. 2006;8:222. doi:10.1186/ar2075.
7. Totterman SMS. Magnetic resonance imaging of psoriatic arthritis: insight from
traditional and three-dimensional analysis. Curr Rheumatol Rep. 2004;6:317–21.
8. Link TM, Li X. Bone marrow changes in osteoarthritis. Semin Musculoskelet Radiol.
2011;15:238–46. doi:10.1055/s-0031-1278423.
9. Boesen M, Kubassova O, Sudoł-Szopińska I, Maas M, Hansen P, Nybing JD, et al. MR
Imaging of Joint Infection and Inflammation with Emphasis on Dynamic Contrast-Enhanced
MR Imaging. PET Clin. 2018;13:523–50. doi:10.1016/j.cpet.2018.05.007.
10. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation
for the apparent dissociation between clinical remission and continued structural
deterioration in rheumatoid arthritis. Arthritis Rheum. 2008;58:2958–67. doi:10.1002/art.23945.
11. Hodgson R, Grainger A, O’Connor P, Barnes T, Connolly S, Moots R. Dynamic contrast
enhanced MRI of bone marrow oedema in rheumatoid arthritis. Ann Rheum Dis. 2008;67:270–2.
doi:10.1136/ard.2007.077271.
12. Hodgson RJ, O’Connor P, Moots R. MRI of rheumatoid arthritis image quantitation
for the assessment of disease activity, progression and response to therapy. Rheumatology.
2008;47:13–21. doi:10.1093/rheumatology/kem250.
13. Ungvari Z, Tarantini S, Kiss T, Wren JD, Giles CB, Griffin CT, et al. Endothelial
dysfunction and angiogenesis impairment in the ageing vasculature. Nat Rev Cardiol.
2018;15:555–65. doi:10.1038/s41569-018-0030-z.
14. Findlay DM, Kuliwaba JS. Bone-cartilage crosstalk: a conversation for understanding
osteoarthritis. Bone Res. 2016;4:16028. doi:10.1038/boneres.2016.28.
15. Roemer FW, Frobell R, Hunter DJ, Crema MD, Fischer W, Bohndorf K, et al. MRI-detected
subchondral bone marrow signal alterations of the knee joint: terminology, imaging
appearance, relevance and radiological differential diagnosis. Osteoarthr Cartil.
2009;17:1115–31. doi:10.1016/j.joca.2009.03.012.
16. Alliston T, Hernandez CJ, Findlay DM, Felson DT, Kennedy OD. Bone marrow lesions
in osteoarthritis: what lies beneath. J Orthop Res. 2017;36:1818–25. doi:10.1002/jor.23844.
17. van der Heijde D. Remission by imaging in rheumatoid arthritis: should this be
the ultimate goal? Ann Rheum Dis. 2012;71 Suppl 2:i89-92. doi:10.1136/annrheumdis-2011-200797.
18. Borrero CG, Mountz JM, Mountz JD. Emerging MRI methods in rheumatoid arthritis.
Nat Rev Rheumatol. 2011;7:85–95. doi:10.1038/nrrheum.2010.173.